Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodensteiner, K.J.
Right arrow Articles by Sawyer, H.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodensteiner, K.J.
Right arrow Articles by Sawyer, H.R.
Agricola
Right arrow Articles by Bodensteiner, K.J.
Right arrow Articles by Sawyer, H.R.
Biology of Reproduction 62, 1479-1485 (2000)
© 2000 Society for the Study of Reproduction, Inc.


Articles

Expression of Growth and Differentiation Factor-9 in the Ovaries of Fetal Sheep Homozygous or Heterozygous for the Inverdale Prolificacy Gene (FecXI)1

K.J. Bodensteinera, K.P. McNattyb, C.M. Claya, C.L. Moellera, and H.R. Sawyer2,a

a Animal Reproduction and Biotechnology Laboratory, Department of Physiology, Colorado State University, Fort Collins, Colorado 80523 b AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Abnormal follicular and oocyte growth in ovaries of sheep homozygous (II) for the Inverdale gene, FecXI, suggest that this gene may influence a fundamental event in initiation of folliculogenesis, with two copies of the gene inhibiting growth at the primordial/primary stage. In addition, striking similarities in ovarian morphology between mice deficient in growth and differentiation factor-9 (GDF-9) and II sheep suggest a relationship between the FecXI gene and GDF-9 function in the ovary. Therefore, it was hypothesized that GDF-9 mRNA expression would be inhibited in ovaries of II fetal sheep. To test this hypothesis, in situ hybridization was used to characterize GDF-9 mRNA expression in ovaries of homozygous (II), heterozygous (I+), and control (++) fetal sheep at Day 135 of gestation. GDF-9 mRNA expression was localized exclusively to oocytes from the type 1 follicle stage onward in all genotypes and is the first demonstration of GDF-9 mRNA expression in ovaries of fetal sheep. In addition, GDF-9 mRNA expression was detected in oocytes of abnormal type 2 follicles in the ovaries of II sheep. Thus, it does not appear that inhibition of GDF-9 gene expression is the mechanism of action whereby the FecXI gene exerts its influence. However, the possibility of translation at specific stages of follicular development cannot presently be ruled out. In addition, the FecXI gene may be involved, either directly or indirectly, in regulating expression of receptors for GDF-9. At present, however, neither the FecXI gene product nor the GDF-9 receptor has been isolated or characterized.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The Inverdale fecundity gene, FecXI, is a mutation on the X chromosome affecting ovulation rate in sheep. In animals heterozygous for the FecXI gene (I+), ovulation rate is increased by >= 1 over noncarriers (++) [1]. In contrast, animals homozygous for the FecXI gene (II) have "streak" gonads and are sterile [2]. Fetal II sheep demonstrate normal germ cell development and follicular formation until approximately Day 100 of gestation. However, as ovarian follicles start to grow (i.e., from Day 100 onward), development beyond the primary stage is impaired, and normal secondary follicles are not observed [3, 4]. Disruption of normal folliculogenesis at this stage of development appears to be due to a lack of granulosa cell proliferation as oocytes increase in diameter to >40 µm [3, 5]. As a result, ovaries of II sheep contain many abnormal follicles characterized by an enlarged oocyte and lacking a normal complement of granulosa cells. In addition, follicles with oocytes at various stages of degeneration and oocyte-free follicles, or "nodules," are observed [3, 4]. Thus, compared to other genotypes, it seems that a fundamental event in early follicular growth is impaired in II animals during late fetal, neonatal, and adult life. Whether the FecXI mutation affects oocyte development, granulosa cell differentiation, or both is not known [3]. Thus, studies designed to examine the cellular and intraovarian effects of this gene have the potential to provide insight into the mechanisms controlling initiation of folliculogenesis and oocyte development.

The signal(s) and mechanism(s) that regulate gonadotropin-independent folliculogenesis are unknown. Although the potential role of a number of growth factors and their receptors in preantral follicular growth has been examined, the majority of these factors are not expressed until after follicular growth has been initiated (for review see [6, 7]). Recently, a novel member of the transforming growth factor ß superfamily, termed growth and differentiation factor-9 (GDF-9), was shown to be expressed in oocytes of domestic ruminants from the primordial follicle stage onward [8]. The observed oocyte specificity and timing of GDF-9 expression is consistent with the concept that this growth factor may be important in initiation of folliculogenesis in these species; however, the precise role of GDF-9 in gonadotropin-independent folliculogenesis in sheep remains obscure.

Interestingly, GDF-9-deficient mice have a phenotype similar to that in II sheep. For example, follicular development is arrested at the primary follicle stage, associated granulosa cells fail to proliferate, and antral cavities and thecal cell layers are not formed [9, 10]. Furthermore, lack of GDF-9 leads to an abnormal increase in oocyte size, with eventual loss of the oocyte and formation of steroidogenic granulosa cell clusters [11]. Collectively, these data suggest that GDF-9 and the FecXI gene product play fundamental roles in the regulation of preantral follicular growth and oocyte development. Although GDF-9 has been mapped to chromosome 5 in sheep [12] and, therefore, is not a candidate for the Inverdale mutation, it is possible that the FecXI gene could affect GDF-9 expression. Because of the phenotypic similarities between II sheep and GDF-9-deficient mice, we hypothesized that expression of GDF-9 would be inhibited in oocytes in ovaries of II fetal sheep. To test this hypothesis, expression of GDF-9 mRNA in ovaries of II, I+, and ++ sheep at Day 135 of gestation was examined using in situ hybridization.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Collection of Tissue Samples

All experiments were performed with approval granted from the Animal Ethics Committee of the Invermay Agricultural Centre and the Wallaceville Animal Research Centre, and in accordance with the 1987 Animal Protection (Codes of Ethical Conduct) Regulations of New Zealand.

I+ and ++ female fetuses were obtained by mating progeny-tested I rams (n = 3) with I+ ewes that were themselves derived from progeny-tested I rams. Each fetus was assigned to either the II or I+ genotype from analyses of DNA extracts of muscle tissue recovered from the hind leg. Although the Inverdale genetic mutation is unknown, genotype was determined using three DNA markers (Inv 12, Inv 17, and Inv 07) [13]. Authentic female I+ fetuses were generated by mating progeny-tested rams (n = 2) with ++ ewes. The ++ female fetuses were generated by mating noncarrier rams (n = 3) with ++ ewes.

Fetuses (n = 4 per genotype: II, I+, and ++) were recovered via cesarean section at 135 days of gestation (day of mating = Day 0). Ovaries were removed from fetuses and immersion-fixed in 4% (w:v) phosphate-buffered paraformaldehyde, pH 7.4, for 24 h. Tissue was trimmed and embedded in paraffin (Paraplast; Oxford Laboratory Ware, St. Louis, MO), and serial sections were cut (5–7 µm thick) and transferred to microscope slides coated with 3-aminopropyltriethoxysilane (Aldrich Chemical Company, Milwaukee, WI). Slides were then shipped to the Animal Reproduction and Biotechnology Laboratory at Colorado State University (Fort Collins, CO) for in situ hybridization and examination of mRNA expression.

Use of c-kit and Follistatin

Expression of c-kit mRNA has been localized to oocytes from the primordial (type 1) follicle stage onward in fetal sheep [14], and expression of follistatin mRNA has been detected in granulosa cells of follicles from the secondary (type 3) follicle stage onward in adult sheep [6, 15]. In addition, follistatin mRNA expression has been detected in the oocyte-free follicles, or nodules, of II adult sheep (Dr. J. Juengel, personal communication). Thus, in the present study, in situ hybridizations for c-kit and follistatin served as positive controls for oocyte and granulosa cell expression respectively. Further, follistatin expression in the nodules of II sheep facilitated identification of these structures and, in some cases, allowed for analysis of GDF-9 expression in adjacent sections.

Probe Preparation

A 277-base pair (bp) genomic fragment of ovine GDF-9 exon 2 was cloned into pBS/KS (Stratagene, La Jolla, CA) and digested with either BamHI (T7; antisense) or XbaI (T3; sense) restriction endonucleases for the production of riboprobes [8]. Plasmid DNA (pGEM-3Z; Promega, Madison, WI) containing a 422-bp ovine c-kit cDNA was linearized for the production of riboprobes with either KpnI (SP6; antisense) or PstI (T7; sense) restriction endonucleases [14]. Plasmid DNA (pGEM-3Z; Promega) containing a 726-bp ovine follistatin cDNA was digested with EcoRI (SP6; antisense) or XbaI (T7; sense) for riboprobe production [16].

In Situ Hybridization

Expression of mRNAs encoding ovine GDF-9, c-kit, and follistatin was examined using in situ hybridization as previously described [8, 17] with modifications from Tisdall et al. [15]. Tissue sections (5–7 µm thick) were deparaffinized by immersion in Hemo-De (Fisher Scientific, Pittsburgh, PA) two times for 10 min each time and hydrated by passage through graded alcohols (100–70%) and diethyl pyrocarbonate (DEPC)-treated water for 3 min. Slides were then incubated in 0.2 M HCl for 20 min at room temperature and washed in double-strength SSC (single-strength SSC is 0.15 M sodium chloride, 0.015 M sodium citrate) for 30 min at room temperature. Proteinase K digestion was performed for 5 min at 37°C (proteinase K solution = 2 µg/ml proteinase K [Sigma, St. Louis, MO]; 0.2 M Tris HCl [pH 7.2]; 50 mM EDTA [pH 8.0]). Slides were then dipped in triethanolamine (0.1 M, pH 8.0), incubated in 0.25% acetic anhydride in 0.1 M triethanolamine for 10 min, dipped in double-strength SSC, dehydrated through graded alcohols (50–100%) and air-dried. After linearization of plasmid, antisense and sense 35S[UTP]-labeled riboprobes were generated with the appropriate promoters. Sixty microliters (2 x 107 cpm/ml) of RNA probe in hybridization buffer (for 40 ml: 25 ml deionized formamide, 3.75 ml 4 M NaCl, 0.5 ml 1 M Tris pH 8.0, 1 ml 50-strength Denhardt's solution, 10 ml 50% dextran sulfate, 0.75 ml double-distilled H2O, and 200 mM dithiothreitol) was added to each slide and covered with a glass coverslip. Sections hybridized to GDF-9 and c-kit were incubated overnight in a humidified chamber at 50°C and sections hybridized to follistatin were incubated at 55°C. After hybridization, coverslips were removed by soaking in double-strength SSC. Sections were then washed in double-strength SSC for 10 min, incubated in a ribonuclease (RNase)-A solution (Sigma; 600 µl 10 mg/ml RNase-A into 300 ml double-strength SSC) at 37°C for 30 min, washed in double-strength SSC for 10 min and in a stringent wash solution (0.1-strength SSC, 0.09% ß-mercaptoethanol, 1 mM EDTA) at 55 or 60°C for 2 h (GDF-9 at 55°C; c-kit and follistatin at 60°C), and rinsed twice in 0.5-strength SSC for 10 min. Sections were dehydrated through graded ethanol-ammonium acetate solutions (50–100% ethanols; 0.3 M NH4OAc) and air-dried. Slides were then coated with NTB2 emulsion (Eastman Kodak, Rochester, NY) and stored at 4°C for 22 or 32 days (GDF-9 and c-kit = 32 days; follistatin = 22 days). Emulsion was developed, and tissue sections were stained with hematoxylin and eosin and examined using both brightfield and darkfield optics.

Classification of Follicles

Classification of follicles was based on the scheme developed by Lundy et al. [18]. In this classification system, five well-defined stages of follicular growth from primordial to early antral are recognized. Criteria used to classify ovine follicles into specific developmental stages included the number and appearance of granulosa cells, layers of granulosa cells, and follicle/oocyte diameters. Primordial follicles are classified as type 1 follicles and are characterized by a single layer of squamous granulosa cells. Type 1a follicles are also characterized by a single layer of granulosa cells, but one or more of the granulosa cells surrounding the oocyte are cuboidal. Type 2 follicles are commonly referred to as primary follicles and have 1 to <2 complete layers of cuboidal granulosa cells. Characteristics of subsequent stages using this classification scheme are as follows: type 3, small preantral follicles with 2 to <4 layers of cuboidal granulosa cells; type 4, large preantral follicles with 4–6 layers of cuboidal granulosa cells; and type 5, small antral follicles with >5 layers of granulosa cells and an antral cavity. In the present study, an additional follicle type was added to account for large antral follicles and included all follicles >450 µm in diameter. The percentage of follicles per type that expressed GDF-9, c-kit, or follistatin was determined in all follicles in which the plane of section included the oocyte nucleus. Only nonatretic follicles were considered in the study.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Ovarian Morphology

On Day 135 of gestation, normal follicles from all stages of follicular development (types 1–5) were observed in the ovaries of I+ and ++ sheep. In contrast, normal follicles beyond the type 2 stage were not detected in II sheep. There was no evidence of abnormal follicular structures or abnormal primary follicles in the ovaries of I+ and ++ animals. However, abnormal type 2 follicles characterized by an enlarged oocyte and an abnormal arrangement of granulosa cells were present in all four of the II sheep examined. Furthermore, of the four II animals studied, all had clearly identifiable oocyte-free follicles, or nodules.

Expression of mRNA Encoding GDF-9, c-kit, and Follistatin

In situ hybridization was used to detect follicles that expressed GDF-9, c-kit, and follistatin mRNAs in ovaries of II, I+, and ++ sheep at Day 135 of gestation. The numbers of follicles examined for each follicular class (types 1–5), genotype, and growth factor are summarized in Table 1. In each of the three genotypes, type 1a follicles were the most numerous and ranged from 64–77% of the total number of follicles evaluated.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Number of follicles expressing GDF-9, c-kit, and follistatin in sections of ++, I+, and II fetal ovaries*

Distribution of silver grains over sections of fetal ovaries incubated with the 35S-radiolabeled antisense probe for GDF-9 appeared to be oocyte-specific in all three genotypes (Fig. 1), and oocytes in all follicles from the type 1 follicle stage onward were labeled. Specific hybridization was not evident in any other cell type, including granulosa and theca cells. Enlarged oocytes of abnormal type 2 follicles (total = 21 follicles; Fig. 1A) in the ovaries of II sheep also expressed GDF-9 mRNA, but specific binding of GDF-9 antisense probe to oocyte-free follicles, or nodules, in the ovaries of II fetal sheep was not observed.



View larger version (183K):
[in this window]
[in a new window]
 
FIG. 1. In situ localization of mRNA for GDF-9 in oocytes present in II, I+, and ++ fetal ovaries at Day 135 of gestation. A) Type 1 and 1a follicles and an abnormal type 2 follicle from a II sheep hybridized to GDF-9 35S-antisense probe. B) Adjacent section hybridized to GDF-9 35S-sense probe. C) Type 4 follicle from a I+ sheep hybridized to GDF-9 antisense probe. D) Adjacent section incubated in the presence of GDF-9 35S-sense probe. E) Putative type 5 follicle from a ++ sheep incubated in the presence of GDF-9 35S-antisense probe. F) Adjacent section hybridized to GDF-9 35S-sense probe

Similar to the case with GDF-9, specific hybridization of the 35S-radiolabeled antisense probe for c-kit was detected in all oocytes from the type 1 follicle stage onward in II, I+, and ++ fetal ovaries (Fig. 2). In addition, c-kit mRNA expression was noted in granulosa cells of type 4 and large antral follicles from I+ and ++ sheep (Fig. 2C). Although granulosa cells in several additional large preantral and antral follicles in the ovaries of I+ and ++ sheep were positive for c-kit expression, the plane of section did not include the nucleus of the oocyte. Therefore, these follicles were not included in data summarized in Table 1. Specific hybridization to other ovarian cell types, including thecal and stromal tissue, was not observed. Although oocytes of abnormal type 2 follicles in the ovaries of II sheep expressed c-kit mRNA (total = 36 follicles; Fig. 2B), specific hybridization to abnormal ovarian structures, including oocyte-free nodules, was not noted (Fig. 2B).



View larger version (159K):
[in this window]
[in a new window]
 
FIG. 2. In situ localization of mRNA for c-kit in oocytes present in II and I+ fetal ovaries at Day 135 of gestation. A) Type 1 and 1a follicles from a II sheep hybridized to c-kit 35S-antisense probe. B) Abnormal type 2 follicles from a II sheep hybridized to c-kit 35S-antisense probe. Note the lack of specific expression in the nodule (arrow). C) Type 4 follicle from a I+ sheep incubated in the presence of c-kit antisense probe. Both the oocyte and the granulosa cells are positive for c-kit. D) Lower magnification of the same area in the adjacent section incubated in the presence of c-kit 35S-sense probe. Type 1, 1a, and 4 follicles are visible

Expression of follistatin mRNA was restricted to granulosa cells of type 4 and larger follicles in I+ and ++ sheep (Fig. 3B) and was not apparent in oocytes or theca cells at any stage of development examined. Although follistatin expression was detected in granulosa cells of several putative type 3 follicles, the plane of section did not include the oocyte nucleus, and therefore these follicles were not included in the final count. Furthermore, and consistent with the blockage in folliculogenesis at the type 2 stage in II sheep, granulosa cells in follicles from these sheep did not express mRNA for follistatin. Nevertheless, follistatin mRNA expression was detected in the oocyte-free nodules of II sheep (Fig. 3A).



View larger version (90K):
[in this window]
[in a new window]
 
FIG. 3. In situ localization of mRNA for follistatin in oocytes present in II and I+ fetal ovaries at Day 135 of gestation. A) Section from a II sheep hybridized to follistatin 35S-antisense probe. Nodules are positive for follistatin (arrows), but granulosa cells from type 1 and 1a follicles do not demonstrate expression. B) Type 4 follicle from a I+ sheep incubated in the presence of follistatin antisense probe. C) Adjacent section incubated in the presence of follistatin 35S-sense probe

Specific labeling was not observed in sections incubated with 35S-radiolabeled sense probe for GDF-9 (Fig. 1, B, D, and F), c-kit (Fig. 2D), or follistatin (Fig. 3C).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Specific hybridization of the 35S-labeled GDF-9 antisense probe was limited exclusively to oocytes in follicles from the type 1 stage onward in all genotypes. Although the observed oocyte-specific expression of GDF-9 mRNA in ovaries of fetal sheep is consistent with that reported for adult sheep, cattle [8], and mice [1921], GDF-9 mRNA was not detected in fetal mouse ovaries [19]. This is not unexpected, however, since folliculogenesis does not begin until the perinatal period in mice [22].

In domestic ruminants, onset of GDF-9 gene expression begins at the type 1 follicle stage ([8]; present study). This is in contrast to data from mice, in which GDF-9 mRNA expression was not observed until the primary follicle stage [19, 20]. Apparent differences in onset of GDF-9 expression in these species could be due to differences in follicular classification criteria, to sensitivity of the in situ hybridization system used, or to species differences. However, since GDF-9 mRNA expression from the type 1 (primordial) follicle stage has recently been documented in mice [21], it seems likely that discrepancies in GDF-9 mRNA expression between rodents and ruminants are due to procedural differences in the in situ hybridization methodology (e.g., tissue fixation or length of exposure).

In all studies to date, ovarian expression of GDF-9 mRNA has been localized exclusively to oocytes [8, 1921]. Consistent with this, we did not detect GDF-9 mRNA in oocyte-free follicles, or nodules, in ovaries of II sheep. In contrast, GDF-9 mRNA expression was observed in enlarged oocytes of abnormal type 2 follicles. Thus, despite the putative role of GDF-9 in granulosa cell proliferation and development [9, 11], it would not appear that a lack of GDF-9 gene expression underlies the development of abnormal ovarian structures in II sheep. Clearly, however, we cannot preclude the possibility of a lesion in either GDF-9 protein expression or signaling that may contribute to the abnormal follicular development observed in II sheep.

Specific hybridization for mRNA encoding the tyrosine kinase receptor, c-kit, was localized to oocytes of all follicles from the type 1 stage onward, regardless of genotype. In addition, c-kit mRNA expression was noted in granulosa cells of large preantral and antral follicles in I+ and ++ sheep. Patterns of c-kit mRNA expression in the present study correspond to those reported previously for sheep [14] and are similar to patterns of expression that have been noted in mice [2325]. Consistent with data reported for adults [6, 15], follistatin mRNA expression was localized to granulosa cells in I+ and ++ sheep but was not detected in granulosa cells of II sheep. Thus, lack of c-kit and follistatin mRNA expression in granulosa cells of II fetal sheep confirms the blockage in folliculogenesis at the type 2 stage of development. In addition, and similar to patterns of expression seen in GDF-9-deficient mice [11], follistatin gene expression was detected in the oocyte-free follicles, or nodules, of II sheep. Expression of follistatin in these structures allowed for positive identification of the nodules and, in some cases, allowed for comparison of GDF-9 mRNA expression in the same structures in nearby sections. Hence, in situ hybridization for c-kit and follistatin mRNAs served as reliable positive controls for both oocyte and granulosa cell gene expression.

The large number of type 1a follicles observed in the present study is consistent with data from cattle [26] and rats [27], in which the majority of follicles had a single layer of granulosa cells with at least one cuboidal cell. Although it is thought that the transition of granulosa cells from squamous to cuboidal is indicative of the initiation of follicular growth, the large number of type 1a follicles in the ovaries of these species suggests that this follicle type does not, in its entirety, represent a transitional stage. Rather, it has been proposed that this follicle type represents a morphologically distinct population of nongrowing primordial follicles together with a portion of follicles developing from the type 1 stage [2628]. Thus, new markers for the initiation of follicular growth and revision of current follicular classification schemes may be necessary.

In summary, regardless of genotype or stage of development, all oocytes expressed mRNA for GDF-9. On the basis of these results, it appears that phenotypic characteristics of ovaries in II sheep are not due to a lack of expression of mRNA for GDF-9 or alteration in cell- or stage-specific expression of c-kit or follistatin. Although inhibition of GDF-9 gene expression does not appear to be the mechanism of action by which the FecXI gene alters folliculogenesis in II or I+ sheep, the possibility of translation at specific stages of follicular development cannot presently be ruled out. In addition, the FecXI gene may be involved, either directly or indirectly, in regulating expression of receptors for GDF-9. At present, however, neither the FecXI gene product nor the GDF-9 receptor has been isolated or characterized.


    ACKNOWLEDGMENTS
 
The authors would like to thank Sue Galloway, Molecular Biology Unit, Otago University, Dunedin, for identification of Inverdale genotypes; Dr. David Tisdall, National Centre for Disease Investigation, Wallaceville, New Zealand, for the c-kit and follistatin cDNA probes; and our colleagues at Wallaceville Animal Research Centre, Upper Hutt, New Zealand, namely, Peter Smith for recovery of ovaries, Lee-Ann Still for histology, Doug Jensen for animal care and management, and Dr. Jenny Juengel for advice during conduct of the experiments.


    FOOTNOTES
 
First decision: 1 December 1999.

1 Supported by the Colorado State University Agricultural Experiment Station and USDA NRICGP Award Number: 990-2389. K.J.B. was supported by NIH National Research Service Award Number HG07031. Back

2 Correspondence: H.R. Sawyer, Animal Reproduction and Biotechnology Laboratory, Foothills Campus, Colorado State University, Fort Collins, CO 80523. FAX: 970 491 3557; hsawyer{at}cvmbs.colostate.edu Back

Accepted: December 31, 1999.

Received: November 2, 1999.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Davis GH, McEwan JC, Fennessy PF, Dodds KG, Farquhar PA. Evidence for the presence of a major gene influencing ovulation rate on the X-chromosome of sheep. Biol Reprod 1991; 44:620–624.[Abstract]
  2. Davis GH, McEwan JC, Fennessy PF, Dodds KG, McNatty KP, O W-S. Infertility due to bilateral ovarian hypoplasia in sheep homozygous (FecXI FecXI) for the Inverdale prolificacy gene located on the X-chromosome. Biol Reprod 1992; 46:636–640.[Abstract]
  3. Braw-Tal R, McNatty KP, Smith P, Heath DA, Hudson NL, Phillips DJ, McLeod BJ, Davis GH. The ovaries of ewes homozygous for the X-linked Inverdale gene (FecXI) are devoid of secondary and tertiary follicles but contain many abnormal structures. Biol Reprod 1993; 49:895–907.[Abstract]
  4. Smith P, O W-S, Corrigan KA, Smith T, Lundy T, Davis GH, McNatty KP. Ovarian morphology and endocrine characteristics of female sheep fetuses that are heterozygous or homozygous for the Inverdale prolificacy gene (FecXII). Biol Reprod 1997; 57:1183–1192.[Abstract]
  5. McNatty KP, Smith P, Hudson NL, Lun S, Heath D, Shackell G, and Corrigan K. Ovarian characteristics in Inverdale ewes heterozygous (I+) and homozygous (II) for the Inverdale gene (FecX). Proc N Z Soc Anim Prod 1995; 55:301–303.
  6. McNatty KP, Heath DA, Lundy T, Fidler AE, Quirke L, O'Connell A, Smith P, Groome N, Tisdall DJ. Control of early ovarian follicular development. J Reprod Fertil Suppl 1999; 54:3–16.[Medline]
  7. Elvin JA, Matzuk MM. Mouse models of ovarian failure. Rev Reprod 1998; 3:183–195.[Abstract]
  8. Bodensteiner KJ, Clay CM, Moeller CL, Sawyer HR. Molecular cloning of the ovine growth/differentiation factor-9 gene and expression of growth/differentiation factor-9 in ovine and bovine ovaries. Biol Reprod 1999; 60:381–386.[Abstract/Free Full Text]
  9. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996; 383:531–535.[CrossRef][Medline]
  10. Carabatsos MJ, Elvin J, Matzuk MM, Albertini DF. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol 1998; 204:373–384.[CrossRef][Medline]
  11. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM. Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 1999; 13:1018–1034.[Abstract/Free Full Text]
  12. Sadighi M, Montgomery GW, Bodensteiner KJ, Galloway SM. The growth differentiation factor-9 gene maps to sheep chromosome 5. International Society on Animal Genetics, XXVI International Conference on Animal Genetics, "Animal Genetics at the Threshold of the Twenty-first Century," Auckland, New Zealand. Anim Genet 1998; 19(suppl 1):36.
  13. Galloway SM, Cambridge LM, Henry HM, Van Stijn TC, Davis GH. A genetic test to identify carriers of the ovine Inverdale fecundity gene. Proc N Z Soc Anim Prod 1999; 59:114–116.
  14. Clark DE, Tisdall DJ, Fidler AE, McNatty KP. Localization of mRNA encoding c-kit during the initiation of folliculogenesis in ovine fetal ovaries. J Reprod Fertil 1996; 106:329–335.[Abstract/Free Full Text]
  15. Tisdall DJ, Hudson N, Smith P, McNatty KP. Localization of ovine follistatin and {alpha} and ßA inhibin mRNA in the sheep ovary during the oestrous cycle. J Mol Endocrinol 1994; 12:181–193.[Abstract/Free Full Text]
  16. Tisdall DJ, Hill DF, Peterson GB, Fleming JS. Ovine follistatin: characterization of cDNA and expression in sheep ovary during the luteal phase of the oestrous cycle. J Mol Endocrinol 1992; 8:259–264.[Abstract/Free Full Text]
  17. Eckery DC, Moeller CL, Nett TM, Sawyer HR. Localization and quantification of binding sites for follicle-stimulating hormone, luteinizing hormone, growth hormone, and insulin-like growth factor 1 in sheep ovarian follicles. Biol Reprod 1997; 57:507–513.[Abstract]
  18. Lundy T, Smith P, O'Connell A, Hudson NL, McNatty KP. Populations of granulosa cells in small follicles of the sheep ovary. J Reprod Fertil 1999; 155:251–262.
  19. McGrath SA, Esquela AF, Lee S-J. Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 1995; 9:131–136.[Abstract/Free Full Text]
  20. Fitzpatrick SL, Sindoni DM, Shughrue PJ, Lane MV, Merchenthaler IJ, Frail DE. Expression of growth differentiation factor-9 messenger ribonucleic acid in ovarian and nonovarian rodent and human tissues. Endocrinology 1998; 139:2571–2578.[Abstract/Free Full Text]
  21. Laitinen M, Vuojolainen K, Jaatinen R, Ketola I, Aaltonen J, Lehtonen E, Heikinheimo M, Ritvos O. A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech Dev 1998; 78:135–140.[CrossRef][Medline]
  22. Richards JS. Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol Rev 1980; 60:51–89.[Free Full Text]
  23. Manova K, Huang EJ, Angeles M, DeLeon V, Sanchez S, Pronovost SM, Besmer P, Bachvarova RF. The expression of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia. Dev Biol 1993; 157:85–99.[CrossRef][Medline]
  24. Horie K, Takakura K, Taii S, Narimoto K, Noda Y, Nishikawa S, Nakayama H, Fujita J, Mori T. The expression of c-kit protein during oogenesis and early embryonic development. Biol Reprod 1991; 45:547–552.[Abstract]
  25. Yoshida H, Takakura N, Kataoka H, Kunisada T, Okamura H, Nishikawa S-I. Stepwise requirement of c-kit tyrosine kinase in mouse ovarian follicle development. Dev Biol 1997; 184:122–137.[CrossRef][Medline]
  26. van Wezel IL, Rogers RJ. Morphological characterization of bovine primordial follicles and their environment in vivo. Biol Reprod 1996; 55:1003–1011.[Abstract]
  27. Meredith S, Dudenhoeffer G, Jackson K. Two distinct pools of primordial follicles exist in rats. Biol Reprod 1999; 60(suppl 1):269 [abstract 567].
  28. McNatty KP, Fidler AE, Juengel JL, Quirke LD, Smith PR, Heath DA, Lundy T, O'Connell A, Tisdall DJ. Growth and paracrine factors regulating follicular formation and cellular function. Mol Cell Endocrinol 1999; (in press).



This article has been cited by other articles:


Home page
ReproductionHome page
A. T Grazul-Bilska, J. S Caton, W. Arndt, K. Burchill, C. Thorson, E. Borowczyk, J. J Bilski, D. A Redmer, L. P Reynolds, and K. A Vonnahme
Cellular proliferation and vascularization in ovine fetal ovaries: effects of undernutrition and selenium in maternal diet
Reproduction, April 1, 2009; 137(4): 699 - 707.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
E. A McLaughlin and S. C McIver
Awakening the oocyte: controlling primordial follicle development
Reproduction, January 1, 2009; 137(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S Elis, J Dupont, I Couty, L Persani, M Govoroun, E Blesbois, F Batellier, and P Monget
Expression and biological effects of bone morphogenetic protein-15 in the hen ovary
J. Endocrinol., September 1, 2007; 194(3): 485 - 497.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
L J Spicer, P Y Aad, D Allen, S Mazerbourg, and A J Hsueh
Growth differentiation factor-9 has divergent effects on proliferation and steroidogenesis of bovine granulosa cells.
J. Endocrinol., May 1, 2006; 189(2): 329 - 339.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Clelland, G. Kohli, R. K. Campbell, S. Sharma, S. Shimasaki, and C. Peng
Bone Morphogenetic Protein-15 in the Zebrafish Ovary: Complementary Deoxyribonucleic Acid Cloning, Genomic Organization, Tissue Distribution, and Role in Oocyte Maturation
Endocrinology, January 1, 2006; 147(1): 201 - 209.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. J. Bodensteiner, H. R. Sawyer, C. L. Moeller, C. M. Kane, K.-Y. F. Pau, G. R. Klinefelter, and D. N. R. Veeramachaneni
Chronic Exposure to Dibromoacetic Acid, a Water Disinfection Byproduct, Diminishes Primordial Follicle Populations in the Rabbit
Toxicol. Sci., July 1, 2004; 80(1): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Jackowski, J. E. Rehg, Y.-M. Zhang, J. Wang, K. Miller, P. Jackson, and M. A. Karim
Disruption of CCT{beta}2 Expression Leads to Gonadal Dysfunction
Mol. Cell. Biol., June 1, 2004; 24(11): 4720 - 4733.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. P. Hanrahan, S. M. Gregan, P. Mulsant, M. Mullen, G. H. Davis, R. Powell, and S. M. Galloway
Mutations in the Genes for Oocyte-Derived Growth Factors GDF9 and BMP15 Are Associated with Both Increased Ovulation Rate and Sterility in Cambridge and Belclare Sheep (Ovis aries)
Biol Reprod, April 1, 2004; 70(4): 900 - 909.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. Shimasaki, R. K. Moore, F. Otsuka, and G. F. Erickson
The Bone Morphogenetic Protein System In Mammalian Reproduction
Endocr. Rev., February 1, 2004; 25(1): 72 - 101.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. Mandon-Pepin, A. Oustry-Vaiman, B. Vigier, F. Piumi, E. Cribiu, and C. Cotinot
Expression Profiles and Chromosomal Localization of Genes Controlling Meiosis and Follicular Development in the Sheep Ovary
Biol Reprod, March 1, 2003; 68(3): 985 - 995.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. X. Liao, R. K. Moore, F. Otsuka, and S. Shimasaki
Effect of Intracellular Interactions on the Processing and Secretion of Bone Morphogenetic Protein-15 (BMP-15) and Growth and Differentiation Factor-9. IMPLICATION OF THE ABERRANT OVARIAN PHENOTYPE OF BMP-15 MUTANT SHEEP
J. Biol. Chem., January 31, 2003; 278(6): 3713 - 3719.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. A. Logan, J. L. Juengel, and K. P. McNatty
Onset of Steroidogenic Enzyme Gene Expression During Ovarian Follicular Development in Sheep
Biol Reprod, April 1, 2002; 66(4): 906 - 916.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodensteiner, K.J.
Right arrow Articles by Sawyer, H.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodensteiner, K.J.
Right arrow Articles by Sawyer, H.R.
Agricola
Right arrow Articles by Bodensteiner, K.J.
Right arrow Articles by Sawyer, H.R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS